Company profile: JDS Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of specialty pharmaceutical solutions focused on developing prescription psychiatry products.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to JDS Pharmaceuticals
Cenes
HQ: United Kingdom
Website
- Description: Provider of biopharmaceutical products, developing and commercializing drugs for pain control, sedation, and other central nervous system disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cenes company profile →
AskBio
HQ: United States
Website
- Description: Provider of AAV-based gene therapies for genetic disorders and rare diseases, offering proprietary AAV technology, manufacturing capabilities, and in-house clinical programs. Pipeline includes AB-1002 for advanced heart failure (GenePHIT Phase 2), ACT-101 for late-onset Pompe disease, and NAN-101 for congestive heart failure, plus research on AAV immune responses and episome configuration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AskBio company profile →
Link Medicine
HQ: United States
Website
- Description: Provider of research aimed at creating disease-modifying therapies for neurodegenerative diseases, including Alzheimer's and Parkinson's disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Link Medicine company profile →
Sequent Medical
HQ: United States
Website
- Description: Provider of innovative catheter-based neurovascular technologies, including proprietary Microbraid™ technology used to create the WEB™ Aneurysm Embolization System for the treatment of neurovascular diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sequent Medical company profile →
Tryp Therapeutics
HQ: Canada
Website
- Description: Provider of clinical-stage psilocybin-based therapeutics, developing an IV infusion of psilocin and synthetic oral psilocybin to address neuropsychiatric disorders, orphan diseases, and conditions with no effective first-line treatments. Offerings include TRP-8803, a proprietary IV psilocin formulation, TRP-8802 in early-stage trials, and Phase 2a studies in fibromyalgia, binge eating disorder, and irritable bowel syndrome.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tryp Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for JDS Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to JDS Pharmaceuticals
2.2 - Growth funds investing in similar companies to JDS Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for JDS Pharmaceuticals
4.2 - Public trading comparable groups for JDS Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →